https://recallregister.com/fda/i/99778/
https://recallregister.com/fda/i/99778/
ASAIO Journal 72(7):p e151-e155, July 2026. | Read the full article here: https://ow.ly/nJ4p5107WjX
#ASAIOJ #Myocarditis #ECMO # Impella #ECPELLA #CardiacICU
ASAIO Journal 72(7):p e151-e155, July 2026. | Read the full article here: https://ow.ly/nJ4p5107WjX
#ASAIOJ #Myocarditis #ECMO # Impella #ECPELLA #CardiacICU
ASAIO Journal 72(7):p e144-e147, July 2026. | Read the full study here: https://ow.ly/Oiyh5107E4X
#ASAIOJ #RenalFunction #HeartTransplant #BridgeToTransplant #impella #CKD
ASAIO Journal 72(7):p e144-e147, July 2026. | Read the full study here: https://ow.ly/Oiyh5107E4X
#ASAIOJ #RenalFunction #HeartTransplant #BridgeToTransplant #impella #CKD
Mahathi Kari, a DevOps engin...
https://ohsem.me/2026/11/mahathi-kari-receives-2026-global-recognition-award-for-ai-cybersecurity-and-engineering-expertise/?utm_source=bluesky&utm_medium=social
Mahathi Kari, a DevOps engin...
https://ohsem.me/2026/11/mahathi-kari-receives-2026-global-recognition-award-for-ai-cybersecurity-and-engineering-expertise/?utm_source=bluesky&utm_medium=social
Educational, not medical advice.
Educational, not medical advice.
Additional Details Here.
Additional Details Here.
Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or…
United States · Source: US Food and Drug Administration
#Recall #DrugRecall #USA
Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or…
United States · Source: US Food and Drug Administration
#Recall #DrugRecall #USA
Date: 2026-11-09
Salim Rezaie, MD (@srrezaie77) from ResusX:ReUnion:
DanGer Shock is the first RCT showing mortality benefit with Impella, and an NNT of 8. Does this shift your escalation threshold? Comment and discuss.👇
Salim Rezaie, MD (@srrezaie77) from ResusX:ReUnion:
DanGer Shock is the first RCT showing mortality benefit with Impella, and an NNT of 8. Does this shift your escalation threshold? Comment and discuss.👇
László Gábor húszéves egyetemista szeptember 24-én egy konditeremben esett össze, és a helyszínen nem tért vissza a spontán keringése. A Semmelweis Egyetem Városmajori Szív- és Érgyógyászati Klinikáján ECMO-val, majd Magyarországon…
László Gábor húszéves egyetemista szeptember 24-én egy konditeremben esett össze, és a helyszínen nem tért vissza a spontán keringése. A Semmelweis Egyetem Városmajori Szív- és Érgyógyászati Klinikáján ECMO-val, majd Magyarországon…
Salim Rezaie, MD (@srrezaie77) from ResusX:ReUnion:
Before DanGer Shock, the answer was none of them. Drop your thoughts below.
Salim Rezaie, MD (@srrezaie77) from ResusX:ReUnion:
Before DanGer Shock, the answer was none of them. Drop your thoughts below.
Salim Rezaie, MD (@srrezaie77) from ResusX:ReUnion:
The DanGer Shock Trial tested exactly this in 355 patients. What's your answer? Drop it in the comments.👇
Salim Rezaie, MD (@srrezaie77) from ResusX:ReUnion:
The DanGer Shock Trial tested exactly this in 355 patients. What's your answer? Drop it in the comments.👇
🔎 successful single-center series (2020–2025) including 5 adolescents
@asaiojournal.bsky.social #PedsICU
🖇️ bit.ly/4eIlKwu
🔎 successful single-center series (2020–2025) including 5 adolescents
@asaiojournal.bsky.social #PedsICU
🖇️ bit.ly/4eIlKwu
🫀 Johnson & Johnson reported three clinical analyses showing lower mortality for patients on Impella heart pumps during high-risk coronary procedures than rates in the CHIP-BCIS3 trial.
#JNJ
https://financier.news/
🫀 Johnson & Johnson reported three clinical analyses showing lower mortality for patients on Impella heart pumps during high-risk coronary procedures than rates in the CHIP-BCIS3 trial.
#JNJ
https://financier.news/
ロボット支援手術で使うダヴィンチやhinotoriもカッコ良いネーミング🐦
DBHでは「アンドロイドが手術をする」となっているが、実際は「人間が手術をするのを助ける」ロボットになっているんですよね。今後もしばらくはそうした方向で行くんじゃなかろうかと思います。フィジカルAIが医療に参入するのはしばらく先かな・・・?
ロボット支援手術で使うダヴィンチやhinotoriもカッコ良いネーミング🐦
DBHでは「アンドロイドが手術をする」となっているが、実際は「人間が手術をするのを助ける」ロボットになっているんですよね。今後もしばらくはそうした方向で行くんじゃなかろうかと思います。フィジカルAIが医療に参入するのはしばらく先かな・・・?
ASAIO Journal 72(7):p e102-e107, July 2026. | https://ow.ly/K5to5100RuL
#ASAIOJ #AdultCirculatorySupport #HeartTransplant #Impella5.5 #IABP
ASAIO Journal 72(7):p e102-e107, July 2026. | https://ow.ly/K5to5100RuL
#ASAIOJ #AdultCirculatorySupport #HeartTransplant #Impella5.5 #IABP
#Cardiology #Diagnostics #ClinicalValidation
#Cardiology #Diagnostics #ClinicalValidation
Thorsten Sieß von Johnson & Johnson MedTech erhält dieses Jahr die Auszeichnung für seine bahnbrechende Entwicklung der IMPELLA™-Technologie, aus der die heute kleinste Herzpumpe der Welt hervorging, sowie deren erfolgreiche Vermarktung.
Thorsten Sieß von Johnson & Johnson MedTech erhält dieses Jahr die Auszeichnung für seine bahnbrechende Entwicklung der IMPELLA™-Technologie, aus der die heute kleinste Herzpumpe der Welt hervorging, sowie deren erfolgreiche Vermarktung.